Clinical Trials
- Lung, Diseases of the Respiratory Systems
PICFLU2: Discovering the immunobiology of influenza critical illness in young people
- Heart/Cardiovascular
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) (CADENCE)
- Ages18 years - 85 years
- GenderBoth
- Heart/Cardiovascular
TARGET BP I Clinical Trial (TARGET BP I)
- Ages18 years - 80 years
- GenderBoth